VitaNova Life Sciences Statistics
Total Valuation
VNOV has a market cap or net worth of 19.84 million. The enterprise value is 18.67 million.
| Market Cap | 19.84M |
| Enterprise Value | 18.67M |
Important Dates
The next estimated earnings date is Wednesday, December 16, 2026.
| Earnings Date | Dec 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VNOV has 8.34 million shares outstanding.
| Current Share Class | 8.34M |
| Shares Outstanding | 8.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.48% |
| Owned by Institutions (%) | n/a |
| Float | 1.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.12 |
| PB Ratio | 10.29 |
| P/TBV Ratio | 10.29 |
| P/FCF Ratio | 35.59 |
| P/OCF Ratio | 35.59 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 33.49 |
Financial Position
The company has a current ratio of 7.13
| Current Ratio | 7.13 |
| Quick Ratio | 6.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.02% and return on invested capital (ROIC) is -22.17%.
| Return on Equity (ROE) | -6.02% |
| Return on Assets (ROA) | -2.40% |
| Return on Invested Capital (ROIC) | -22.17% |
| Return on Capital Employed (ROCE) | -4.47% |
| Weighted Average Cost of Capital (WACC) | 1.59% |
| Revenue Per Employee | 463,316 |
| Profits Per Employee | -16,301 |
| Employee Count | 7 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 15.28 |
Taxes
In the past 12 months, VNOV has paid 30,963 in taxes.
| Income Tax | 30,963 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +340.74% in the last 52 weeks. The beta is -0.48, so VNOV's price volatility has been lower than the market average.
| Beta (5Y) | -0.48 |
| 52-Week Price Change | +340.74% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.69 |
| Average Volume (20 Days) | 957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VNOV had revenue of 3.24 million and -114,104 in losses. Loss per share was -0.01.
| Revenue | 3.24M |
| Gross Profit | 872,329 |
| Operating Income | -86,121 |
| Pretax Income | -83,141 |
| Net Income | -114,104 |
| EBITDA | n/a |
| EBIT | -86,121 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.60 million in cash and no debt, with a net cash position of 1.60 million or 0.19 per share.
| Cash & Cash Equivalents | 1.60M |
| Total Debt | n/a |
| Net Cash | 1.60M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 1.93M |
| Book Value Per Share | 0.23 |
| Working Capital | 1.91M |
Cash Flow
| Operating Cash Flow | 557,561 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 557,561 |
| FCF Per Share | 0.07 |
Margins
Gross margin is 26.90%, with operating and profit margins of -2.66% and -3.52%.
| Gross Margin | 26.90% |
| Operating Margin | -2.66% |
| Pretax Margin | -2.56% |
| Profit Margin | -3.52% |
| EBITDA Margin | n/a |
| EBIT Margin | -2.66% |
| FCF Margin | 17.19% |
Dividends & Yields
VNOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.58% |
| FCF Yield | 2.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2026. It was a reverse split with a ratio of 0.3333333.
| Last Split Date | Jan 27, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.3333333 |
Scores
VNOV has an Altman Z-Score of 50.49 and a Piotroski F-Score of 3.
| Altman Z-Score | 50.49 |
| Piotroski F-Score | 3 |